Diagnostic validity of serum macrophage inhibitor cytokine and tissue polypeptide-specific antigen in pancreatobiliary diseases

Pancreatology

Volumn 11, Issue 3, 2011, Pages 295-300

  Özkan, Hasan ^a   Demirbaş, Selma ^a   Ibiş, Mehmet ^b   Akbal, Erdem ^c   Köklü, Seyfettin ^c,d  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Ba larba i Mahallesi   (Turkey)

Author keywords

CA 19 9; Macrophage inhibitory cytokine 1; Pancreatic cancer; Pancreatobiliary diseases; Tissue polypeptide specific antigen; Tumor marker

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CYTOKINE; PROTEIN MACROPHAGE INHIBITORY CYTOKINE; TISSUE POLYPEPTIDE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILIARY TRACT TUMOR; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SERUM; VALIDITY; VOLUNTEER;

EID: 79960244539     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000328963     Document Type: Article

References (26)

1. Bootcov MR, Bauskin AR, Valenzuela SM, et al: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily cluster. Proc Natl Acad Sci USA 1997;94:11514-11519. (Pubitemid 27451030)
2. Wiklund FE, Bennet AM, Magnusson PK, et al: Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 2010;9:1057-1064.
3. Ding Q, Mracek T, Gonzalez-Muniesa P, et al: Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009;150:1688-1696.
4. Böttner M, Suter-Crazzolara C, Schober A, et al: Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 1999;297:103-110. (Pubitemid 29313281)
5. Schober A, Böttner M, Strelau J, et al: Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol 2001;439:32-45.
6. Fairlie WD, Moore AG, Bauskin AR, et al: MIC-1 is a novel TGF-h superfamily cytokine associated with macrophage activation. J Leukocyte Biol 1999;65:2-5. (Pubitemid 29024911)
7. Brown DA, Ward RL, Buckhaults P, et al: MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9:2642-2650. (Pubitemid 36842108)
8. Brown DA, Ward RL, Buckhaults P, et al: MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9:2642-2650. (Pubitemid 36842108)
9. Wollmann W, Goodman ML, Bhat-Nakshatri P, et al: The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 2005;26:900-907. (Pubitemid 41214318)
10. Bauskin AR, Brown DA, Kuffner T, et al: Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006;66:4983-4986. (Pubitemid 43852864)
11. Nakamura T, Scorilas A, Stephan C, et al: Quantitative analysis of macrophage inhibitory cytokine-1 gene expression in human prostatic tissues. Br J Cancer 2003;88:1101-1104. (Pubitemid 36560783)
12. Koopmann J, Rosenzweig CN, Zhang Z, et al: Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA 19-9. Clin Cancer Res 2006;12:442-446. (Pubitemid 43166133)
13. Koopmann J, Buckhaults P, Brown DA, et al: Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004;10:2386-2392. (Pubitemid 38445697)
14. Kornek G, Schenk T, Raderer M, et al: Tissue polypeptide-specific antigen in monitoring palliative treatment response of patients with gastrointestinal tumours. Br J Cancer 1995;71:182-185.
15. Glimelius B, Hoffman K, Einarsson R, et al: Monitoring palliative chemotherapy in advanced gastrointestinal cancer using serial tissue polypeptide-specific antigen measurements. Acta Oncol 1996;35:141-148. (Pubitemid 26155138)
16. Pasanen PA, Eskelinen M, Partanen K, et al: A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide-specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. Br J Cancer 1994;69:562-565. (Pubitemid 24076480)
17. Banfi G, Zerbi A, Pastori S, et al: Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and followup of pancreatic cancer. Clin Chem 1993;39:420-423. (Pubitemid 23099006)
18. Slesak B, Harlozinska-Szmyrka A, Knast W, et al: TPS and CA 19-9 measurements in the follow-up of patients with pancreatic cancer and chronic pancreatitis. Int J Biol Markers 2004;19:115-119. (Pubitemid 39106936)
19. Slesak B, Harlozinska-Szmyrka A, Knast W, et al: Tissue polypeptide-specific antigen, a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9. Cancer 2000;89:83-88. (Pubitemid 30451277)
20. Ohkawara T, Nishihira J, Takeda H, et al: Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders. J Gastroenterol 2005;40:117-122. (Pubitemid 40425197)
21. Johansson U, Olsson A, Gabrielsson S, et al: Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003;308:474-479. (Pubitemid 36945516)
22. Waeber G, Calandra T, Roduit R, et al: Insulin secretion is regulated by the glucose-dependent production of islet β-cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997;94:4782-4787. (Pubitemid 27194321)
23. Sakai Y, Masamune A, Satoh A, et al: Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003;124:725-736. (Pubitemid 36277650)
24. Rahman SH, Menon KV, Holmfield JH, et al: Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis. Ann Surg 2007;245:282-289. (Pubitemid 46148488)
25. Golkar L, Ding XZ, Ujiki MB, et al: Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res 2007;138:163-169. (Pubitemid 46365718)
26. Ozkan H, Akat T, Köklü S, et al: Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases. Pancreatology 2006;6:268-272. (Pubitemid 44329077)